Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference75 articles.
1. De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol (Lausanne). 2018;9:2.
2. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17(1):83.
3. Indicators for the Australian National Diabetes Strategy 2016–2020: data update 09 December 2020. https://www.aihw.gov.au/reports/diabetes/diabetes-indicators-strategy-2016-2020/contents/goal-3-reduce-the-occurrence-of-diabetes-related-complications-improve-quality-of-life/indicator-3-7-prevalence-of-cardiovascular-disease-among-people-with-diabetes. Accessed 15 May 2022.
4. Baker IDI Heart and Diabetes Institute. Diabetes: the silent pandemic and its impact on Australia. Melbourne: Baker IDI Heart and Diabetes Institute. 2012. https://www.baker.edu.au/-/media/Documents/impact/diabetes-the-silent-pandemic.ashx?la=en. Accessed 5 Mar 2022.
5. Taylor KS, Heneghan CJ, Farmer AJ, Fuller AM, Adler AI, Aronson JK, et al. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large UK primary care database. Diabetes Care. 2013;36(8):2366–71.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献